Alvarez-Curto Elisa, Inoue Asuka, Jenkins Laura, Raihan Sheikh Zahir, Prihandoko Rudi, Tobin Andrew B, Milligan Graeme
From the Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom,
the Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan, and.
J Biol Chem. 2016 Dec 30;291(53):27147-27159. doi: 10.1074/jbc.M116.754887. Epub 2016 Nov 16.
G protein-coupled receptors (GPCRs) can initiate intracellular signaling cascades by coupling to an array of heterotrimeric G proteins and arrestin adaptor proteins. Understanding the contribution of each of these coupling options to GPCR signaling has been hampered by a paucity of tools to selectively perturb receptor function. Here we employ CRISPR/Cas9 genome editing to eliminate selected G proteins (Gα and Gα) or arrestin2 and arrestin3 from HEK293 cells together with the elimination of receptor phosphorylation sites to define the relative contribution of G proteins, arrestins, and receptor phosphorylation to the signaling outcomes of the free fatty acid receptor 4 (FFA4). A lack of FFA4-mediated elevation of intracellular Ca in Gα/Gα-null cells and agonist-mediated receptor internalization in arrestin2/3-null cells confirmed previously reported canonical signaling features of this receptor, thereby validating the genome-edited HEK293 cells. FFA4-mediated ERK1/2 activation was totally dependent on G/ but intriguingly was substantially enhanced for FFA4 receptors lacking sites of regulated phosphorylation. This was not due to a simple lack of desensitization of G/ signaling because the G/-dependent calcium response was desensitized by both receptor phosphorylation and arrestin-dependent mechanisms, whereas a substantially enhanced ERK1/2 response was only observed for receptors lacking phosphorylation sites and not in arrestin2/3-null cells. In conclusion, we validate CRISPR/Cas9 engineered HEK293 cells lacking G/ or arrestin2/3 as systems for GPCR signaling research and employ these cells to reveal a previously unappreciated interplay of signaling pathways where receptor phosphorylation can impact on ERK1/2 signaling through a mechanism that is likely independent of arrestins.
G蛋白偶联受体(GPCRs)可通过与一系列异源三聚体G蛋白和抑制蛋白衔接蛋白偶联来启动细胞内信号级联反应。由于缺乏选择性干扰受体功能的工具,了解这些偶联选项中的每一个对GPCR信号传导的贡献受到了阻碍。在这里,我们采用CRISPR/Cas9基因组编辑技术,从HEK293细胞中消除选定的G蛋白(Gα和Gα)或抑制蛋白2和抑制蛋白3,同时消除受体磷酸化位点,以确定G蛋白、抑制蛋白和受体磷酸化对游离脂肪酸受体4(FFA4)信号转导结果的相对贡献。在Gα/Gα缺失的细胞中缺乏FFA4介导的细胞内Ca升高,以及在抑制蛋白2/3缺失的细胞中缺乏激动剂介导的受体内化,证实了先前报道的该受体的典型信号特征,从而验证了基因组编辑的HEK293细胞。FFA4介导的ERK1/2激活完全依赖于G/,但有趣的是,对于缺乏调节磷酸化位点的FFA4受体,其激活程度显著增强。这并不是由于G/信号简单地缺乏脱敏作用,因为G/依赖的钙反应通过受体磷酸化和抑制蛋白依赖的机制均发生了脱敏,而仅在缺乏磷酸化位点的受体中观察到ERK1/2反应显著增强,在抑制蛋白2/3缺失的细胞中则未观察到。总之,我们验证了缺乏G/或抑制蛋白2/3的CRISPR/Cas9工程化HEK293细胞作为GPCR信号研究系统,并利用这些细胞揭示了信号通路之间以前未被认识到的相互作用,即受体磷酸化可以通过一种可能独立于抑制蛋白的机制影响ERK1/2信号传导。